Insulin resistance reduces the response of the body’s cells to insulin, which can stimulate the liver to synthesize more fatty acids and result in the accumulation of fat in the liver, exacerbating the progression of NAFLD. The gene discussed is INS; the disease is metabolic dysfunction-associated steatotic liver disease.